Cheil Bio Co

Cheil Bio Co EPS

Delisted·Feb 25, 2026

The Earnings per Share (EPS) of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is -15.40 KRW. In the previous year, Earnings per Share (EPS) was -53.52 KRW — a change of -71.22% (higher).

EPS

-15.40KRW

YoY

-71.22%

Last updated:

Earnings per Share (EPS) of Cheil Bio Co is 2024 -15.40 KRW. Earnings per Share (EPS) of Cheil Bio Co was 2023 -53.52 KRW. It decreases by -71.22% higher compared to the previous year.

The Cheil Bio Co EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2017
56.80 KRW
Jan 1, 2018
77.63 KRW
Jan 1, 2019
152.47 KRW
Jan 1, 2020
36.79 KRW
Jan 1, 2021
-26.37 KRW
Jan 1, 2022
-63.23 KRW
Jan 1, 2023
-53.52 KRW
Jan 1, 2024
-15.40 KRW
The Cheil Bio Co EPS history
YEAREPSYoY
-15.40KRW-71.22%
-53.52KRW-15.34%
-63.23KRW+139.73%
-26.37KRW-171.68%
36.79KRW-75.87%
152.47KRW+96.40%
77.63KRW+36.68%
56.80KRW+51.31%
37.54KRW+19.05%
31.53KRW-10.89%
35.39KRW+116.85%
16.32KRW-65.01%
46.64KRW+70.15%
27.41KRW+11.05%
24.68KRW+16.52%
21.18KRW-143.96%
-48.18KRW+130.94%
-20.86KRW-240.37%
14.86KRW+267.22%
4.05KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Earnings per Share (EPS) of Cheil Bio Co is -15.40 KRW in 2024.

Earnings per Share (EPS) of Cheil Bio Co changed from -53.52 KRW to -15.40 KRW, representing a -71.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Cheil Bio Co

All Key Metrics — Cheil Bio Co